Article
Targeting telomerase for cancer therapeutics
29 Jan 2008
Abstract excerpt
One of the hallmarks of advanced malignancies is continuous cell growth and this almost universally correlates with the reactivation of telomerase. Although there is still much we do not understand about the regulation of telomerase, it remains a very attractive and novel target for cancer therapeutics. Several clinical trials have been initiated, and in this review we highlight some of the most promising...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
